Business Description
![Amplia Therapeutics Ltd Amplia Therapeutics Ltd logo](https://static.gurufocus.com/logos/0C0000AJKZ.png?14)
Amplia Therapeutics Ltd
ISIN : AU0000023822
Description
Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure-play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.13 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | -0.37 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 17.4 | |||||
3-Year FCF Growth Rate | 4.7 | |||||
3-Year Book Growth Rate | -14.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 69.91 | |||||
9-Day RSI | 69.46 | |||||
14-Day RSI | 67.47 | |||||
6-1 Month Momentum % | -21.54 | |||||
12-1 Month Momentum % | -27.86 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.98 | |||||
Quick Ratio | 1.98 | |||||
Cash Ratio | 0.99 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -21.1 | |||||
Shareholder Yield % | -0.2 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -32.16 | |||||
ROA % | -26.44 | |||||
ROIC % | -85.94 | |||||
ROC (Joel Greenblatt) % | -365 | |||||
ROCE % | -31.47 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.75 | |||||
Price-to-Tangible-Book | 4.4 | |||||
EV-to-EBIT | -5.05 | |||||
EV-to-EBITDA | -5.15 | |||||
EV-to-FCF | -5 | |||||
Price-to-Net-Current-Asset-Value | 4.4 | |||||
Earnings Yield (Greenblatt) % | -19.81 | |||||
FCF Yield % | -21.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Amplia Therapeutics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | |||
EPS (TTM) (A$) | -0.023 | ||
Beta | 0.66 | ||
Volatility % | 34.76 | ||
14-Day RSI | 67.47 | ||
14-Day ATR (A$) | 0.008506 | ||
20-Day SMA (A$) | 0.06565 | ||
12-1 Month Momentum % | -27.86 | ||
52-Week Range (A$) | 0.055 - 0.135 | ||
Shares Outstanding (Mil) | 274.21 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Amplia Therapeutics Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Amplia Therapeutics Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
Amplia Therapeutics Ltd Frequently Asked Questions
What is Amplia Therapeutics Ltd(ASX:ATX)'s stock price today?
The current price of ASX:ATX is A$0.09. The 52 week high of ASX:ATX is A$0.14 and 52 week low is A$0.06.
When is next earnings date of Amplia Therapeutics Ltd(ASX:ATX)?
The next earnings date of Amplia Therapeutics Ltd(ASX:ATX) is .
Does Amplia Therapeutics Ltd(ASX:ATX) pay dividends? If so, how much?
Amplia Therapeutics Ltd(ASX:ATX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |